1. Home
  2. BLLN vs SON Comparison

BLLN vs SON Comparison

Compare BLLN & SON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$109.83

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Logo Sonoco Products Company

SON

Sonoco Products Company

N/A

Current Price

$50.10

Market Cap

4.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
BLLN
SON
Founded
2016
1899
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.9B
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
BLLN
SON
Price
$109.83
$50.10
Analyst Decision
Buy
Buy
Analyst Count
8
10
Target Price
★ $129.00
$57.13
AVG Volume (30 Days)
456.0K
★ 1.3M
Earning Date
11-04-2026
10-21-2026
Dividend Yield
N/A
★ 4.32%
EPS Growth
103.40
★ 510.30
EPS
★ 0.48
N/A
Revenue
$305,112,000.00
★ $7,518,753,000.00
Revenue This Year
$49.33
N/A
Revenue Next Year
$26.38
$1.57
P/E Ratio
$237.01
★ N/A
Revenue Growth
★ 99.97
41.72
52 Week Low
$61.96
$39.27
52 Week High
$150.44
$60.67

Technical Indicators

Market Signals
Indicator
BLLN
SON
Relative Strength Index (RSI) 52.83 50.95
Support Level $89.26 $46.78
Resistance Level $127.72 $51.10
Average True Range (ATR) 5.53 1.49
MACD 1.15 0.14
Stochastic Oscillator 60.41 67.15

Price Performance

Historical Comparison
BLLN
SON

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About SON Sonoco Products Company

Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.

Share on Social Networks: